Sunday, May 8, 2022 12:30 PM – 2:30 PM ET Oregon Ballroom 202
Vaccines and Immunity against Bacteria and Parasites
- JoAnne L. Flynn, Univ. of Pittsburgh Sch. of Med.
- David A. Rosen, Washington Univ. Sch. of Med.
- Yanli Li, Univ. of North Carolina at Chapel Hill, Identification of CPAF as the immunoprevalent antigen of Chlamydia trachomatis
- Jaikin Harrell, Tulane Univ. Sch. of Med., The use of outer membrane vesicles as novel, mucosal adjuvants against intracellular bactiera
- Matthew Bell, Drexel Univ. Col. of Med., The novel adjuvant, ADA-1, restores age-associated defects in the adaptive immune response to Clostridioides difficile infection and vaccination in an aging mouse model
- Valery Cristina Román-Cruz, Univ. of Montana, Adjuvanted multivalent vaccine targeting clinically relevant Pf bacteriophage creates cross-reactive antibodies
- Paeton L. Wantuch, Washington Univ. Sch. of Med., Differential Immune Response to Klebsiella pneumoniae O-antigen subtypes O2v1 and O2v2
- Andrew W. Simonson, Univ. of Pittsburgh Sch. of Med., The role of lymphocyte subsets in preventing tuberculosis following intravenous vaccination with BCG
- Eva Morgun, Feinberg Sch. of Med., Northwestern Univ., Mycolic acid nanoparticle vaccination leads to antigen persistence and unique differentiation of mycobacterial lipid antigen-specific T cells
- Caroline J. Duncombe, Univ. of Washington, Differential sex-specific immune responses following Prime-and-Trap vaccination alters protection against malaria in mice